4724-10-1 Usage
Description
Methyl 3,5-dihydroxyphenylacetate is a phenylacetic acid derivative, which is a known metabolite of Curvularia Siddiqui. It has been extracted from the culture mycelia of Curvularia lunata supported on a culture medium consisting of yeast, malt extract, and glucose.
Uses
Used in Pharmaceutical Industry:
Methyl 3,5-dihydroxyphenylacetate is used as a reagent for the synthesis of fungal metabolites, specifically cytosporones A, C, J, K, and N. These metabolites have potential applications in the development of new drugs and therapies.
Used in Chemical Synthesis:
Methyl 3,5-dihydroxyphenylacetate is used as a key intermediate in the synthesis of various organic compounds, particularly those with pharmaceutical or biological significance. Its unique structure allows for further functionalization and modification to create novel molecules with potential applications in different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 4724-10-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,2 and 4 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 4724-10:
(6*4)+(5*7)+(4*2)+(3*4)+(2*1)+(1*0)=81
81 % 10 = 1
So 4724-10-1 is a valid CAS Registry Number.
InChI:InChI=1/C9H10O4/c1-13-9(12)4-6-2-7(10)5-8(11)3-6/h2-3,5,10-11H,4H2,1H3
4724-10-1Relevant articles and documents
First total synthesis of medicinally important 3,4,7-trimethoxy-9,10-dihydrophenanthrene-1,5-diol
Gangireddy Venkata, Sivarami Reddy,Narkhede, Umesh C.,Jadhav, Vinod D.,Gangu Naidu, Ch.
, p. 1670 - 1673 (2018/03/29)
The first total synthesis was successfully achieved for biologically active 9,10-dihydrophenanthrene-1,5-diol. The key features of our synthetic approach are Perkin condensation, followed by bromination, palladium mediated intramolecular C-C bond coupling, and selective isopropyl ether cleavage. Synthesized compounds were purified and characterized by IR, 1HNMR, 13CNMR and HRMS/LC-MS.
Syntheses of cytosporones A, C, J, K, and N, metabolites from medicinal fungi
Beekman, Andrew M.,Barrow, Russell A.
, p. 1583 - 1592 (2015/10/20)
The syntheses of the fungal metabolites cytosporones A, (±)-C, and N are reported. And the syntheses of cytosporones J and K are described for the first time. The preparation of racemic cytosporone J and racemic cytosporone K, natural products containing
COMPOUNDS AND COMPOSITIONS AS PPAR MODULATORS
-
Page/Page column 28, (2008/06/13)
The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of the Peroxisome Proliferator-Activated Receptor (PPAR) families.
